BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2284095)

  • 1. The c-ets-1 proto-oncogene has oncogenic activity and is positively autoregulated.
    Seth A; Papas TS
    Oncogene; 1990 Dec; 5(12):1761-7. PubMed ID: 2284095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The EndoA enhancer contains multiple ETS binding site repeats and is regulated by ETS proteins.
    Seth A; Robinson L; Panayiotakis A; Thompson DM; Hodge DR; Zhang XK; Watson DK; Ozato K; Papas TS
    Oncogene; 1994 Feb; 9(2):469-77. PubMed ID: 7507230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.
    Roussel MF; Davis JN; Cleveland JL; Ghysdael J; Hiebert SW
    Oncogene; 1994 Feb; 9(2):405-15. PubMed ID: 8290253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ETS1 and ETS2 in p53 regulation: spatial separation of ETS binding sites (EBS) modulate protein: DNA interaction.
    Venanzoni MC; Robinson LR; Hodge DR; Kola I; Seth A
    Oncogene; 1996 Mar; 12(6):1199-1204. PubMed ID: 8649821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure, expression and alternative splicing of the human c-ets-1 proto-oncogene.
    Reddy ES; Rao VN
    Oncogene Res; 1988; 3(3):239-46. PubMed ID: 3060801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of gene expression by transcription factors Ets-1 and Ets-2.
    Tymms MJ; Kola I
    Mol Reprod Dev; 1994 Oct; 39(2):208-14. PubMed ID: 7826624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization and modulation of the DNA-binding activity of the human c-ets-1 protooncogene.
    Reddy ES; Rao VN
    Cancer Res; 1990 Aug; 50(16):5013-6. PubMed ID: 2165853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversion of Ras transformed cells by Ets transdominant mutants.
    Wasylyk C; Maira SM; Sobieszczuk P; Wasylyk B
    Oncogene; 1994 Dec; 9(12):3665-73. PubMed ID: 7970725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Back-mutation of the V-Ets to the C-Ets carboxy-terminal amino acids in the P135gag-myb-ets results in chicken neuroretina cells transformation and loss of basic fibroblast growth factor responsiveness.
    Garrido C; Leprince D; Plaza S; Aumercier M; Stéhelin D; Saule S
    Oncogene; 1996 Apr; 12(7):1449-56. PubMed ID: 8622861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ets oncogene family.
    Dhulipal PD
    Indian J Exp Biol; 1997 Apr; 35(4):315-22. PubMed ID: 9315229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ets up-regulates MET transcription.
    Gambarotta G; Boccaccio C; Giordano S; Andŏ M; Stella MC; Comoglio PM
    Oncogene; 1996 Nov; 13(9):1911-7. PubMed ID: 8934537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new mechanism of oncogenic activation: E26 retroviral v-ets oncogene has inverted the C-terminal end of the transcription factor c-ets-1.
    Leprince D; Crepieux P; Laudet V; Flourens A; Stehelin D
    Virology; 1993 Jun; 194(2):855-7. PubMed ID: 8389086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ETV6-NTRK3 gene fusion encodes a chimeric protein tyrosine kinase that transforms NIH3T3 cells.
    Wai DH; Knezevich SR; Lucas T; Jansen B; Kay RJ; Sorensen PH
    Oncogene; 2000 Feb; 19(7):906-15. PubMed ID: 10702799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Net (ERP/SAP2) one of the Ras-inducible TCFs, has a novel inhibitory domain with resemblance to the helix-loop-helix motif.
    Maira SM; Wurtz JM; Wasylyk B
    EMBO J; 1996 Nov; 15(21):5849-65. PubMed ID: 8918463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STAT1 and Nmi are downstream targets of Ets-1 transcription factor in MCF-7 human breast cancer cell.
    Jung HH; Lee J; Kim JH; Ryu KJ; Kang SA; Park C; Sung K; Nam DH; Kang WK; Park K; Im YH
    FEBS Lett; 2005 Jul; 579(18):3941-6. PubMed ID: 15996661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse fibroblasts transformed with the human c-myc gene express a high level of mRNA but a low level of c-myc protein and are non-tumorigenic in nude mice.
    Ray R; Thomas S; Miller DM
    Oncogene; 1989 May; 4(5):593-600. PubMed ID: 2657574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of ets-1 and ets-2 proto-oncogenes during murine embryogenesis.
    Maroulakou IG; Papas TS; Green JE
    Oncogene; 1994 Jun; 9(6):1551-65. PubMed ID: 8183549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular cloning and expression of Ehf, a new member of the ets transcription factor/oncoprotein gene family.
    Bochert MA; Kleinbaum LA; Sun LY; Burton FH
    Biochem Biophys Res Commun; 1998 May; 246(1):176-81. PubMed ID: 9600089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoforms of the human ets-1 protein: generation by alternative splicing and differential phosphorylation.
    Koizumi S; Fisher RJ; Fujiwara S; Jorcyk C; Bhat NK; Seth A; Papas TS
    Oncogene; 1990 May; 5(5):675-81. PubMed ID: 2189104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-ets-1 DNA binding to the PEA3 motif is differentially inhibited by all the mutations found in v-ets.
    Leprince D; Crepieux P; Stehelin D
    Oncogene; 1992 Jan; 7(1):9-17. PubMed ID: 1741168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.